These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9968)

  • 21. Blockade of the rate and force responses to phenylephrine on rat atria with labetalol.
    Simpson WW; McNeill JH
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):373-6. PubMed ID: 7414055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the haemodynamic effects of labetalol in man.
    Cohn JN; Mehta J; Francis GS
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):19S-26S. PubMed ID: 7093099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.
    Brittain RT; Drew GM; Levy GP
    Br J Pharmacol; 1982 Sep; 77(1):105-14. PubMed ID: 6127131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
    Pandhi P; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypotensive effect of labetalol on intraocular pressure in rabbits: in relation to its alpha- and beta-adrenergic blocking action on the cardiovascular system.
    Kogure H; Hosaka A; Abiko Y
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):109-22. PubMed ID: 6268004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypotensive and vascular effects of labetalol in the normotensive rat and dog.
    Hashimoto K; Hashimoto T; Iizuka H; Tsukada T; Matsuda H; Imai S
    Jpn Heart J; 1978 Sep; 19(5):762-74. PubMed ID: 32409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of labetalol on the circulatory system (author's transl)].
    Monma Y; Okuoka Y; Kameda H; Ichihara K; Abiko Y; Tanabe T
    Nihon Yakurigaku Zasshi; 1980 May; 76(4):239-54. PubMed ID: 6108907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha- and beta-adrenoceptor blockade by labetalol in human isolated arteries and veins.
    Thulesius O; Gjöres JE; Berlin E
    Br J Clin Pharmacol; 1980 Jun; 9(6):621-3. PubMed ID: 6104500
    [No Abstract]   [Full Text] [Related]  

  • 36. [Alpha- and beta-adrenoceptor blocking actions of labetalol and effects on the myocardial function, coronary circulation and myocardial energy metabolism thereof (author's transl)].
    Katano Y; Takeda K; Nakagawa Y; Hashimoto T; Nakazawa M; Tsukada T; Otorii T; Imai S
    Nihon Yakurigaku Zasshi; 1978 Oct; 74(7):819-32. PubMed ID: 33880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.
    Blakeley AG; Summers RJ
    Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121
    [No Abstract]   [Full Text] [Related]  

  • 38. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
    Koch G
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacology of carvedilol in normal volunteers.
    Cubeddu LX; Fuenmayor N; Varin F; Villagra VG; Colindres RE; Powell JR
    Clin Pharmacol Ther; 1987 Jan; 41(1):31-44. PubMed ID: 3802704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.